Abbott India (ABBOTINDIA.NS) Stock Price

Abbott India Price

CLOSED
26,230.00INR+110.00 (+0.42 %)
Market closed

Over the last 20 years Abbott India grew revenue by 14.3% annually, reaching 64.09 B INR. Earnings per share have grown at 15.2% per year over the last 20 years. For Abbott India, the net margin of 22.1% is up versus 16.0% a few years ago. At today's price the dividend yield works out to roughly 1.81%. The payout ratio is around 71% of earnings. The dividend has grown at 13.9% per year over the past 20 years. The consensus 12-month price target for Abbott India is 37,740.00 INR, about 43.9% above where the stock trades today. Of 12 analysts, 11 rate the stock a buy — an overall Buy consensus. The stock trades about 4% above its 52-week low.

Abbott India stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Abbott India over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Abbott India stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Abbott India's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Abbott India Stock Price History
DateAbbott India Price
8/21/202626,230.00 INR
8/20/202626,120.00 INR
8/19/202626,525.00 INR
8/17/202626,905.00 INR
8/14/202627,060.00 INR
8/13/202628,250.00 INR
8/11/202628,020.00 INR
8/10/202627,535.00 INR
8/7/202627,835.00 INR
8/6/202627,855.00 INR
8/5/202627,785.00 INR
8/4/202627,815.00 INR
7/31/202627,800.00 INR
7/30/202627,790.00 INR
7/28/202627,860.00 INR
7/27/202627,800.00 INR
7/24/202628,005.00 INR
7/23/202628,765.00 INR
7/22/202628,900.00 INR
7/21/202628,800.00 INR
7/20/202628,275.00 INR
7/17/202627,550.00 INR
7/15/202627,640.00 INR
7/14/202627,500.00 INR
7/13/202627,395.00 INR
7/10/202627,165.00 INR
7/9/202626,770.00 INR
7/8/202626,245.00 INR
7/7/202626,725.00 INR
7/6/202626,860.00 INR
7/3/202625,765.00 INR
7/2/202625,725.00 INR
7/1/202625,550.00 INR
6/30/202625,440.00 INR
6/29/202625,295.00 INR
6/25/202625,585.00 INR
6/24/202625,595.00 INR
6/23/202625,570.00 INR
6/22/202626,065.00 INR
6/19/202626,215.00 INR
6/18/202626,145.00 INR
6/17/202625,955.00 INR
6/16/202626,100.00 INR
6/15/202626,255.00 INR
6/12/202626,280.00 INR
6/11/202626,065.00 INR
6/10/202626,345.00 INR
6/9/202626,105.00 INR
6/8/202625,780.00 INR
6/5/202626,035.00 INR
6/4/202625,820.00 INR
6/3/202626,290.00 INR
6/2/202626,295.00 INR
6/1/202626,840.00 INR
5/29/202626,855.00 INR
5/27/202627,735.00 INR
5/26/202627,610.00 INR
5/25/202627,705.00 INR
5/22/202627,830.00 INR
5/21/202627,715.00 INR
5/20/202627,830.00 INR
5/19/202627,795.00 INR
5/18/202627,925.00 INR
5/15/202627,940.00 INR
5/14/202627,520.00 INR
5/13/202627,280.00 INR
5/12/202626,900.00 INR
5/11/202627,795.00 INR
5/8/202626,700.00 INR
5/7/202626,700.00 INR
5/6/202626,300.00 INR
5/5/202625,305.00 INR
5/4/202625,415.00 INR
5/1/202625,435.00 INR
4/30/202625,435.00 INR
4/29/202625,475.00 INR
4/28/202625,345.00 INR
4/27/202625,425.00 INR
4/24/202625,180.00 INR
4/23/202625,410.00 INR
4/22/202625,420.00 INR
4/21/202625,385.00 INR
4/20/202625,550.00 INR
4/17/202625,785.00 INR
4/16/202625,860.00 INR
4/15/202625,975.00 INR
4/13/202625,725.00 INR
4/10/202625,780.00 INR
4/9/202625,780.00 INR
4/8/202625,850.00 INR
4/7/202625,665.00 INR
4/6/202625,895.00 INR
4/2/202626,285.00 INR
4/1/202626,490.00 INR
3/30/202625,900.00 INR
3/27/202626,135.00 INR
3/25/202626,505.00 INR
3/24/202626,860.00 INR
3/23/202625,450.00 INR
3/20/202626,750.00 INR
3/19/202626,515.00 INR
3/18/202626,390.00 INR
3/17/202626,330.00 INR
3/16/202626,695.00 INR
3/13/202626,950.00 INR
3/12/202626,645.00 INR
3/11/202627,150.00 INR
3/10/202626,995.00 INR
3/9/202627,155.00 INR
3/6/202627,325.00 INR
3/5/202627,615.00 INR
2/27/202626,540.00 INR
2/26/202626,355.00 INR
2/25/202626,415.00 INR
2/24/202626,365.00 INR
2/23/202626,425.00 INR
2/20/202626,310.00 INR
2/19/202626,410.00 INR
2/18/202626,460.00 INR
2/17/202626,680.00 INR
2/16/202626,315.00 INR
2/13/202626,500.00 INR
2/12/202626,640.00 INR
2/11/202626,915.00 INR
2/10/202627,315.00 INR
2/9/202627,475.00 INR
2/6/202627,285.00 INR
2/5/202627,110.00 INR
2/4/202627,205.00 INR
2/3/202626,930.00 INR
2/2/202627,290.00 INR
1/30/202627,565.00 INR
1/29/202626,635.00 INR
1/28/202627,655.00 INR
1/27/202627,715.00 INR
1/23/202627,780.00 INR
1/22/202627,785.00 INR
1/21/202627,695.00 INR
1/20/202627,185.00 INR
1/19/202627,750.00 INR
1/16/202627,740.00 INR
1/14/202627,860.00 INR
1/13/202628,100.00 INR
1/12/202628,365.00 INR
1/9/202628,140.00 INR
1/8/202628,400.00 INR
1/7/202628,550.00 INR
1/6/202628,420.00 INR
1/5/202628,155.00 INR
1/2/202628,125.00 INR
1/1/202628,485.00 INR
12/31/202529,025.00 INR
12/30/202528,680.00 INR
12/29/202528,915.00 INR
12/26/202528,905.00 INR
12/24/202528,750.00 INR
12/23/202528,260.00 INR
12/22/202528,010.00 INR
12/19/202528,025.00 INR
12/18/202527,910.00 INR
12/17/202527,640.00 INR
12/16/202527,805.00 INR
12/15/202527,860.00 INR
12/12/202528,010.00 INR
12/11/202528,210.00 INR
12/10/202527,910.00 INR
12/9/202528,075.00 INR
12/8/202528,705.00 INR
12/5/202528,945.00 INR
12/4/202528,800.00 INR
12/3/202528,915.00 INR
12/2/202529,240.00 INR
12/1/202529,800.00 INR
11/28/202530,075.00 INR
11/27/202529,445.00 INR
11/26/202530,020.00 INR
11/25/202530,055.00 INR
11/24/202529,780.00 INR
11/21/202529,530.00 INR
11/20/202529,625.00 INR
11/19/202529,620.00 INR
11/18/202529,720.00 INR
11/17/202529,645.00 INR
11/14/202529,325.00 INR
11/13/202529,570.00 INR
11/12/202529,600.00 INR
11/11/202529,450.00 INR
11/10/202529,500.00 INR
11/7/202528,790.00 INR
11/6/202529,500.00 INR
11/4/202529,365.00 INR
11/3/202529,080.00 INR
10/31/202528,995.00 INR
10/30/202529,575.00 INR
10/29/202529,705.00 INR
10/28/202529,790.00 INR
10/27/202529,775.00 INR
10/24/202529,920.00 INR
10/23/202530,100.00 INR
10/21/202530,255.00 INR
10/20/202529,935.00 INR
10/17/202529,800.00 INR
10/16/202529,850.00 INR
10/15/202529,800.00 INR
10/14/202530,045.00 INR
10/13/202529,995.00 INR
10/10/202530,255.00 INR
10/9/202529,690.00 INR
10/8/202529,865.00 INR
10/7/202529,995.00 INR
10/6/202530,000.00 INR
10/3/202529,965.00 INR
10/1/202529,875.00 INR
9/30/202529,500.00 INR
9/29/202529,665.00 INR
9/26/202529,740.00 INR
9/25/202530,195.00 INR
9/24/202530,195.00 INR
9/23/202530,225.00 INR
9/22/202530,155.00 INR
9/19/202530,365.00 INR
9/18/202530,910.00 INR
9/17/202530,970.00 INR
9/16/202530,900.00 INR
9/15/202530,885.00 INR
9/12/202530,980.00 INR
9/11/202530,900.00 INR
9/10/202530,890.00 INR
9/9/202530,640.00 INR
9/8/202530,950.00 INR
9/5/202531,150.00 INR
9/4/202532,000.00 INR
9/3/202532,575.00 INR
9/2/202532,595.00 INR
9/1/202532,275.00 INR
8/29/202531,500.00 INR
8/28/202531,545.00 INR
8/26/202531,690.00 INR
8/25/202531,530.00 INR
Access this data via the Eulerpool API
Get Free API Key

Abbott India Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
49.19 B INR
10.27 B INR
7.99 B INR
Jan 1, 2023
53.49 B INR
11.41 B INR
9.49 B INR
Jan 1, 2024
58.49 B INR
13.86 B INR
12.01 B INR
Jan 1, 2025
64.09 B INR
16.27 B INR
14.14 B INR
Jan 1, 2026 (e)
69.18 B INR
27.46 B INR
15.71 B INR
Jan 1, 2027 (e)
75.00 B INR
29.77 B INR
17.23 B INR
Jan 1, 2028 (e)
81.49 B INR
32.35 B INR
19.16 B INR
Jan 1, 2029 (e)
90.33 B INR
35.85 B INR
21.19 B INR

Abbott India Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 23, 2026, 12:12 PM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB INR
EBITB INR
EBIT MARGIN%
NET INCOMEB INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
2014201520162017201820192020202120222023202420252026e2027e2028e2029e
22.7622.8926.4629.3933.0736.7940.9343.1049.1953.4958.4964.0969.1875.0081.4990.33
37.710.5615.6011.0812.5411.2311.275.3014.148.739.359.587.938.428.6610.84
42.4042.2942.0140.0241.7142.7342.8744.0645.4843.8944.4544.9844.9844.9844.9844.98
9.659.6811.1111.7613.7915.7217.5518.9922.3723.4826.0028.8331.1133.7336.6540.63
2.543.023.543.865.145.937.078.6910.2711.4113.8616.2727.4629.7732.3535.85
11.1413.1913.3713.1315.5416.1317.2720.1520.8721.3423.6925.3939.6939.6939.6939.69
1.992.292.552.774.014.505.936.917.999.4912.0114.1415.7117.2319.1621.19
37.1815.3711.488.3445.0512.2431.6716.5015.6418.8726.5217.7511.049.7011.2010.58
23.0031.0035.0040.0050.0050.00107.00120.00145.00180.00410.00475.00475.00570.00684.00–
35.2934.7812.9014.2925.00–114.0012.1520.8324.14127.7815.85–20.0020.00–
21.0021.0021.0021.0021.0021.0021.0021.0021.0021.2521.2521.2521.2521.2521.2521.25
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Abbott India generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Abbott India retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Abbott India's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Abbott India has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Abbott India's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Abbott India stock margins

The Abbott India margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Abbott India. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Abbott India.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
44.06 %
20.15 %
16.03 %
Jan 1, 2022
45.48 %
20.87 %
16.24 %
Jan 1, 2023
43.89 %
21.34 %
17.75 %
Jan 1, 2024
44.45 %
23.69 %
20.54 %
Jan 1, 2025
44.98 %
25.39 %
22.07 %
Jan 1, 2026 (e)
44.98 %
39.69 %
22.70 %
Jan 1, 2027 (e)
44.98 %
39.69 %
22.97 %
Jan 1, 2028 (e)
44.98 %
39.69 %
23.51 %

Abbott India Stock Revenue, EBIT, Earnings per Share

The Abbott India earnings per share therefore indicates how much revenue Abbott India has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
2,052.38 INR
413.57 INR
328.90 INR
Jan 1, 2022
2,342.52 INR
489.00 INR
380.33 INR
Jan 1, 2023
2,517.13 INR
537.14 INR
446.80 INR
Jan 1, 2024
2,752.52 INR
652.07 INR
565.30 INR
Jan 1, 2025
3,016.17 INR
765.79 INR
665.64 INR
Jan 1, 2026 (e)
3,255.43 INR
1,292.17 INR
739.10 INR
Jan 1, 2027 (e)
3,529.48 INR
1,400.95 INR
810.80 INR
Jan 1, 2028 (e)
3,835.18 INR
1,522.29 INR
901.61 INR

Abbott India business model & stock analysis

Abbott India Ltd is a leading pharmaceutical company in India that was founded in 1944. Abbott Laboratories, a multinational company from the USA, is the parent company of Abbott India Ltd. Abbott India Ltd is headquartered in Mumbai and specializes in the development, manufacturing, and marketing of products in the healthcare and medical technology sectors. The business model of Abbott India Ltd is based on the development of innovative products and solutions that provide value to customers. The company operates a comprehensive research and development center where it constantly works on new products and technologies to meet the needs of customers. Abbott India Ltd operates in several areas, including pharmaceuticals, diagnostics, and medical technology. The pharmaceutical division includes a wide portfolio of drugs in areas such as gastroenterology, neurology, hormones, and antibiotics. The diagnostics division of Abbott India Ltd provides advanced solutions for disease diagnosis and is a leader in diabetes management, infectious diseases, oncology, and immunology. The medical technology division produces high-quality products, including heart implants, stents, catheters, and pacemakers. Abbott India Ltd is a leading company in the production of dietary supplements and has a wide range of vitamins, minerals, and proteins in its portfolio. Some of the well-known brands of the company include Pedialyte, Similac, EAS, and PediaSure. History: Abbott India Ltd has been active in India since 1944 and has continuously expanded its business. The company started its operations as a trading company distributing vaccines, serum, and diagnostic solutions in India. Abbott India Ltd started pharmaceutical production in 1945 by establishing a pharmaceutical manufacturing facility in Mumbai. Over the years, the production facility has been modernized and expanded to meet the increasing demand for high-quality products. In the 1970s, Abbott India Ltd expanded into the field of diagnostics by introducing advanced testing solutions for healthcare in India. Abbott India Ltd was one of the first companies to introduce advanced tests for hepatitis B in India and has since been a leader in the diagnosis of infectious diseases. In the 1990s, Abbott India Ltd ventured into the field of medical technology by opening a production facility for high-quality implants in Mumbai. The company invested in manufacturing facilities and gained a strong R&D team to develop and manufacture advanced solutions for implants and medical technology in India and other countries. Today, Abbott India Ltd has over 4,000 employees and operates in more than 60 cities in India. The company has built a strong distribution and marketing network to distribute its products throughout India. Summary: Abbott India Ltd is a leading pharmaceutical company in India that offers a wide range of products and solutions for healthcare and medical technology. The company has a profound history and expertise in manufacturing high-quality products and developing advanced solutions for healthcare. Abbott India Ltd is known for its innovative products and services and will continue to play a significant role in the healthcare industry.

Abbott India SWOT Analysis

Strengths

Abbott India Ltd has a strong brand reputation in the pharmaceutical industry, which contributes to its competitive advantage. The company has a wide range of high-quality products in its portfolio, allowing it to cater to various healthcare needs. Abbott India Ltd also has a strong distribution network, enabling it to reach a large customer base efficiently. Furthermore, the company has a robust research and development division, consistently innovating and introducing new products to the market.

Weaknesses

Abbott India Ltd currently faces challenges related to pricing pressures in the pharmaceutical sector. Additionally, the company heavily relies on a few key products for a significant portion of its revenue, making it vulnerable to market fluctuations and patent expirations. Furthermore, the company's high debt burden poses a risk to its financial stability, potentially limiting its growth opportunities.

Opportunities

The growing healthcare sector in India presents significant opportunities for Abbott India Ltd. The increasing focus on preventive healthcare and the rising demand for specialized treatments create a favorable market environment for the company. Furthermore, Abbott India Ltd can explore strategic partnerships and acquisitions to expand its product portfolio and diversify its revenue streams. The expansion into untapped rural markets also holds potential for the company to reach a larger customer base.

Threats

Abbott India Ltd faces threats from intense competition in the pharmaceutical industry, where rival companies often introduce similar products at competitive prices. The strict regulatory environment and frequent policy changes in the healthcare sector pose challenges for the company's operations. Moreover, the emergence of generic drugs and the potential loss of market exclusivity for key products can impact Abbott India Ltd's market share and profitability.

Abbott India Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Abbott India historical P/E ratio, EBIT multiple, and P/S ratio

Abbott India annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Abbott India shares outstanding

The number of shares of Abbott India was 21.25 M in 2025. This indicates how many shares Abbott India is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
21.00 M Stocks
Jan 1, 2022
21.00 M Stocks
Jan 1, 2023
21.25 M Stocks
Jan 1, 2024
21.25 M Stocks
Jan 1, 2025
21.25 M Stocks
Jan 1, 2026 (e)
21.25 M Stocks
Jan 1, 2027 (e)
21.25 M Stocks
Jan 1, 2028 (e)
21.25 M Stocks

Abbott India stock splits

In Abbott India's history, there have been no stock splits.

Abbott India Dividend History

31 years of dividend payments · 6 consecutive increases

YearAnnual DividendYoY ChangePayments
2025475.00INR↑ 15.9%1×
Jul 25, 2025475.00INR↑ 15.9%1/1
2024410.00INR↑ 127.8%1×
2023180.00INR↑ 24.1%1×
2022145.00INR↑ 20.8%1×
2021120.00INR↑ 12.1%1×
2020107.00INR↑ 114.0%1×
201950.00INR 0.0%1×
201850.00INR↑ 25.0%1×
201740.00INR↑ 14.3%1×
201635.00INR↑ 12.9%1×

Abbott India dividend history and estimates

In 2025, Abbott India paid a dividend amounting to 475.00 INR. Dividend means that Abbott India distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
120.00 INR
0.00 INR
Jan 1, 2022
145.00 INR
0.00 INR
Jan 1, 2023
180.00 INR
0.00 INR
Jan 1, 2024
410.00 INR
0.00 INR
Jan 1, 2025
475.00 INR
0.00 INR
Jan 1, 2026
475.00 INR
0.00 INR
Jan 1, 2027 (e)
0.00 INR
570.00 INR
Jan 1, 2028 (e)
0.00 INR
684.00 INR

Abbott India dividend payout ratio

In 2025, Abbott India had a payout ratio of 71.36%. The payout ratio indicates the percentage of the company's profits that Abbott India distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
36.49 %
Jan 1, 2022
38.12 %
Jan 1, 2023
40.29 %
Jan 1, 2024
72.53 %
Jan 1, 2025
71.36 %
Jan 1, 2026 (e)
64.27 %
Jan 1, 2027 (e)
70.30 %
Jan 1, 2028 (e)
75.86 %

Current Abbott India forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
2.07 %
Buy
91.67 % (11)
Hold
8.33 % (1)
Sell
0.00 % (0)
12M Price Target
37,740.00
Last Price
26,230.00
Currency
INR
12M Return Potential
43.88 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Abbott India stock

61/100
56
Environment
58
Social
70
Governance
E

Environment

20
Scope 1 - Direct Emissions298.95
Scope 2 - Indirect emissions from purchased energy4,907.11
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions5,206.06
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees9.911
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Abbott India shareholder structure

% Name
0.85753%
Nippon Life India Asset Management Limited
Nippon Life India Asset Management Limited
0.78552%
Axis Asset Management Company Limited
Axis Asset Management Company Limited
0.36465%
PGIM India Asset Management Private Limited
PGIM India Asset Management Private Limited
0.29683%
HSBC Global Asset Management (India) Private Limited
HSBC Global Asset Management (India) Private Limited
0.24614%
Franklin Templeton Asset Management (India) Pvt. Ltd.
Franklin Templeton Asset Management (India) Pvt. Ltd.
0.13959%
UTI Asset Management Co. Ltd.
UTI Asset Management Co. Ltd.

Abbott India Beneficial Ownership Filings (SEC 13D/G)

Free Float
24.4%
Float Shares
-
Shares Outstanding
-

Abbott India Executives and Management Board

16 members · avg. age 63 · 50 % women

Management

SS

Ms. Sangeeta Shetty

Chief Compliance Officer, Company Secretary, Associate Director - Secretarial

–
SD

Ms. Swati Dalal (57)

Managing Director, Executive Director · since 2010

–

Board of Directors

AV

Mr. Ambati Venu (55)

Non-Executive Director · since 2016

71.50 M INR
MS

Mr. Munir Ahmed Shaikh (80)

Non-Executive Chairman of the Board

3.20 M INR
SK

Ms. Shalini Kamath

Non-Executive Independent Director

3.10 M INR
AM

Ms. Anisha Motwani (61)

Non-Executive Independent Director

3.10 M INR
SJ

Mr. Sudarshan Jain

Non-Executive Independent Director · since 2019

3.00 M INR
KM

Mr. Kaiyomarz Marfatia (67)

Non-Executive Director

2.30 M INR

Frequently asked questions about Abbott India

Abbott India Ltd operates as a leading pharmaceutical company in India. The company's business model primarily focuses on developing, manufacturing, and selling a wide range of healthcare products including pharmaceuticals, diagnostics, nutritional products, and medical devices. Abbott India Ltd follows a diversified approach by serving various therapeutic segments such as neuroscience, gastroenterology, women's health, cardiovascular, metabolic disorders, and more. The company strives to provide innovative and high-quality healthcare solutions to improve the lives of people in India. Abbott India Ltd continuously invests in research and development to bring new and advanced products to the market, reinforcing its position as a trusted and reliable pharmaceutical company.

Abbott India Ltd is primarily active in the pharmaceutical industry. As a leading player in the healthcare sector, Abbott India Ltd focuses on manufacturing and marketing a wide range of pharmaceutical products across multiple therapeutic categories. With its commitment to delivering high-quality healthcare solutions, Abbott India Ltd has established its presence in areas such as gastroenterology, women's health, neuroscience, and cardiovascular care. Through its innovative and diverse product portfolio, Abbott India Ltd strives to improve the lives of patients and contribute to the overall well-being of people in India.

The main competitors of Abbott India Ltd in the market include pharmaceutical companies such as Sun Pharmaceutical Industries Ltd, Cipla Ltd, and Dr. Reddy's Laboratories Ltd. These companies also operate within the Indian pharmaceutical market and offer a range of products and services similar to Abbott India Ltd. However, Abbott India Ltd distinguishes itself through its innovative product portfolio, strong brand reputation, and commitment to research and development.

Abbott India Ltd is a leading pharmaceutical company with a rich history and background. Established in India in 1944, Abbott India has been an integral part of the Indian healthcare sector for over 75 years. The company is a subsidiary of Abbott Laboratories, a global healthcare conglomerate based in the United States. Abbott India Ltd focuses on providing high-quality pharmaceutical products across various therapeutic areas, including neuroscience, gastroenterology, women's health, and cardiovascular diseases. With a strong commitment to innovation, research, and development, Abbott India Ltd has emerged as a trusted name in the Indian pharmaceutical industry, dedicated to improving people's lives through its wide range of healthcare solutions.

Abbott India Ltd has achieved several significant milestones throughout its existence. One noteworthy milestone was the company's establishment in India in 1910, showcasing its long-standing presence in the country. Another important achievement was the successful rebranding and divisional integration with Abbott Laboratories, a global healthcare leader. Additionally, Abbott India Ltd has consistently emerged as a reliable and innovative player in the pharmaceutical and healthcare industry, introducing various breakthrough products and technologies. The company's commitment to quality and patient care has earned it several accolades and certifications, further cementing its strong reputation in the market.

Abbott India Ltd is primarily present in India.

Abbott India Ltd represents a strong set of values and a customer-centric corporate philosophy. The company is committed to improving lives by providing high-quality healthcare products and services. Abbott India focuses on innovation, integrity, and excellence in all its operations, striving to make a positive impact on the healthcare industry. With a customer-driven approach, the company leverages advanced technologies and research to develop and deliver safe and effective healthcare solutions. Abbott India Ltd aims to be a trusted partner in meeting the diverse healthcare needs of the Indian population, reinforcing its commitment to improving overall well-being and driving sustainable growth.

Analysts currently set an average price target of 37,760.40 INR for the Abbott India stock (median: 37,740.00 INR), implying +44.0 % versus the latest price. The consensus is based on 12 analyst ratings.

Abbott India Analyst Price Targets 2026

12 analysts currently rate the Abbott India stock: 11 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Abbott India to generate revenue of 69.18 B INR and earnings per share of 739.10 INR.

Abbott India Analyst Price Targets 2026

Converted at the current exchange rate, the Abbott India share trades at 234.42 EUR (26,230.00 INR).

Abbott India Limited is a leading healthcare company focused on the development and marketing of medical devices, medical diagnostic tools, and pharmaceuticals. The company is headquartered in Mumbai and is a subsidiary of Abbott Laboratories, a global provider of healthcare products. Abbott India operates several business segments, including pharmaceuticals, medical devices, and diagnostics. It is involved in the pharmaceutical industry and offers a wide range of medications for various therapeutic areas such as gastrointestinal disorders, heart diseases, pain management, and antibiotics. The company works closely with its research and development teams to develop innovative medicines for patients worldwide. Abbott India Limited is also a leading provider of medical diagnostic tools, offering a wide range of diagnostic and screening solutions for various diseases such as HIV, hepatitis, diabetes, and cancer. Its products include blood glucose and cholesterol testing devices, rapid tests for infectious diseases, and various laboratory diagnostics. The company's diagnostics division is dedicated to improving healthcare through affordable and accessible testing solutions for a wider population. In addition to offering medications and diagnostic tools, Abbott India is also a leading provider of medical devices and equipment. The company offers a wide range of medical devices for various therapeutic areas, including artificial joints, cardiac implants, stents, and pacemakers. Additionally, the company also provides homecare products, including ventilators and insulin pumps, to enable convenient and cost-effective care for patients. Abbott India Limited strives to improve access to healthcare products and services through innovative business models. It works closely with healthcare providers, physicians, and government agencies to strengthen the healthcare system and improve treatment options. The company also offers various programs and initiatives to enhance patient care, including training and workshops for healthcare professionals to improve patient care. Overall, Abbott India is a leading provider of healthcare products and services focused on improving healthcare in India and globally. The company offers a wide range of medications, medical devices, and diagnostic tools, as well as training programs and initiatives to improve healthcare. Abbott India remains committed to developing innovative solutions and helping patients worldwide lead better lives.

The expected revenue of Abbott India is 69.18 B INR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Abbott India is 15.71 B INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Abbott India is currently 35.49. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Abbott India stock.

The price-to-sales ratio (P/S) of Abbott India is currently 8.06. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Abbott India stock.

The Eulerpool Quality Score for Abbott India is 7/10.

The ISIN of Abbott India is INE358A01014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Abbott India is ABBOTINDIA.NS. The ticker symbol is used to trade Abbott India shares on the stock exchange.

Over the past 12 months, Abbott India paid a dividend of 475.00 INR . This corresponds to a dividend yield of about 1.81 %. For the coming 12 months, Abbott India is expected to pay a dividend of 570.00 INR.

The current dividend yield of Abbott India is 1.81 %.

Abbott India pays a dividend, distributed in the months of , , , .

Abbott India paid dividends every year for the past 31 years.

For the upcoming 12 months, dividends amounting to 570.00 INR are expected. This corresponds to a dividend yield of 2.17 %.

Abbott India is assigned to the 'Health' sector.

To receive the latest dividend of Abbott India from amounting to 475 INR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Abbott India distributed 180 INR as dividends.

The dividends of Abbott India are distributed in INR.

All fundamentals and in-depth analysis of Abbott India

Our stock analysis for Abbott India stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbott India. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Abbott India Stock
Abbott India Revenue→
Abbott India Stock
Abbott India Net Income→
Abbott India Stock
Abbott India P/E→
Abbott India Stock
Abbott India P/S→
Abbott India Stock
Abbott India EBIT→
Abbott India Stock
Abbott India Dividend→
Abbott India Stock
Abbott India Directors Dealings→
Abbott India Stock
Abbott India Stocks→
Abbott India Stock
Abbott India Market capitalization→
Abbott India Stock
Abbott India Debt→
Abbott India Stock
Abbott India Liabilities→
Abbott India Stock
Abbott India Equity→
Abbott India Stock
Abbott India AAQS→
Abbott India Stock
Abbott India Employees→
Abbott India Stock
Abbott India ROE→
Abbott India Stock
Abbott India ROA→
Abbott India Stock
Abbott India ROCE→
Abbott India Stock
Abbott India News→
Abbott India Stock
Abbott India Analyst Price Targets→

Health Stocks

Abbott LaboratoriesAbbisko CaymanAbbVieAb&B Bio Tech Co Ltd JSAbcellera BiologicsAB ScienceAbClonAashka HospitalsAbeona TherapeuticsAarti PharmalabsAbera BioscienceAarti DrugsAll Stocks A–Z →